Arlington Capital Partners Portfolio Company Molecular Products Group Announces Acquisition of the Henkel SODASORB® Business
LOUISVILLE, Colo.–(BUSINESS WIRE)–Molecular Products Group, (“Molecular Products” or the “Company”), a
portfolio company of Arlington Capital Partners (“Arlington Capital”),
today announced the acquisition of the SODASORB® business
from Henkel.
The SODASORB® product range includes carbon dioxide
absorbents which have been trusted globally for decades in the
healthcare and safety industries. SODASORB® products help to
safely and efficiently remove carbon dioxide from anesthesia systems,
saturation diving chambers, diving re-breathers, and industrial safety
equipment.
Troy Rhudy, CEO of the Molecular Products Group, said, “We’re delighted
to add the SODASORB® product line to our existing product
portfolio. The new capacity will enhance our ability to respond to
growing market demands and benefit our entire global customer base,
while strengthening our position as the global leader in carbon dioxide
absorbent technologies.”
“The acquisition of SODASORB® further establishes Molecular
Products in the strategically important healthcare segment of the
business, leveraging the Company’s core chemical technologies and
expanding its capabilities,” said Peter Manos, Managing Partner of
Arlington Capital Partners.
Malcom Little, a Principal of Arlington, added, “This acquisition
demonstrates Molecular Products’ continued focus on highly strategic M&A
to expand the Company’s product offerings and enhance its capabilities
across all of its segments.”
About Molecular Products
Molecular Products is a Pure Air Technologies company and leading
manufacturer of advanced chemistry-based products serving the
healthcare, defense and industrial markets. The Company specializes in
the manufacture and supply of chemical technologies for the treatment of
breathable gases and serves its global customer base out of its two
primary manufacturing facilities in Louisville, Colorado, USA and
Harlow, Essex, UK. www.molecularproducts.com
About Arlington Capital Partners
Arlington Capital Partners is a Washington, D.C.-area private equity
firm that has managed $2.2 billion of committed capital via four
investment funds. Arlington is focused on middle market investment
opportunities in growth industries, including: aerospace/defense,
healthcare, government services and technology, and business services
and software. The firm’s professionals and network have a unique
combination of operating and private equity experience that enable
Arlington to be a value-added investor. Arlington invests in companies
in partnership with high quality management teams that are motivated to
establish and/or advance their Company’s position as leading competitors
in their field. www.arlingtoncap.com
Contacts
Louise Santos
lsantos@molprod.com
633
CTC Blvd.
Louisville, CO 80027
(303) 968-2604
Peter Manos & Malcolm Little
Arlington Capital Partners
5425
Wisconsin Avenue, Suite 200
Chevy Chase, MD 20815
(202)
337-7500
